Wei Qin

4.3k total citations
86 papers, 3.4k citations indexed

About

Wei Qin is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Wei Qin has authored 86 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 22 papers in Cancer Research and 19 papers in Surgery. Recurrent topics in Wei Qin's work include Cancer-related molecular mechanisms research (13 papers), MicroRNA in disease regulation (11 papers) and RNA modifications and cancer (9 papers). Wei Qin is often cited by papers focused on Cancer-related molecular mechanisms research (13 papers), MicroRNA in disease regulation (11 papers) and RNA modifications and cancer (9 papers). Wei Qin collaborates with scholars based in China, Japan and United Kingdom. Wei Qin's co-authors include Arthur C.K. Chung, Hui Y. Lan, Xiao‐Ming Meng, Xiao Ru Huang, David S.C. Hui, Cheuk‐Man Yu, Joseph J.�Y. Sung, Yi Xu, Xiangyu Zhong and Yunfu Cui and has published in prestigious journals such as Cell, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Wei Qin

76 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Qin China 28 2.1k 1.1k 374 359 299 86 3.4k
Shi‐You Chen United States 34 2.0k 0.9× 708 0.6× 469 1.3× 118 0.3× 537 1.8× 128 3.6k
Yue Zhang China 33 2.0k 1.0× 977 0.9× 282 0.8× 78 0.2× 426 1.4× 170 3.6k
Meng Zhao China 29 1.7k 0.8× 348 0.3× 561 1.5× 321 0.9× 362 1.2× 81 3.2k
Limin Li China 35 2.1k 1.0× 1.6k 1.4× 143 0.4× 118 0.3× 404 1.4× 87 3.9k
Sean E. Gill Canada 29 1.2k 0.6× 798 0.7× 542 1.4× 118 0.3× 647 2.2× 64 3.8k
Haiyan Chen China 31 1.9k 0.9× 344 0.3× 250 0.7× 93 0.3× 381 1.3× 112 3.2k
Lijun Wang China 34 2.4k 1.2× 1.0k 0.9× 224 0.6× 49 0.1× 184 0.6× 131 3.8k
Fang Li China 30 2.4k 1.2× 1.6k 1.4× 290 0.8× 181 0.5× 516 1.7× 146 4.4k
Cristiana Tănase Romania 28 767 0.4× 352 0.3× 281 0.8× 241 0.7× 328 1.1× 93 2.6k
Mehryar Habibi Roudkenar Iran 30 1.3k 0.6× 473 0.4× 421 1.1× 260 0.7× 252 0.8× 147 2.9k

Countries citing papers authored by Wei Qin

Since Specialization
Citations

This map shows the geographic impact of Wei Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Qin more than expected).

Fields of papers citing papers by Wei Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Qin. The network helps show where Wei Qin may publish in the future.

Co-authorship network of co-authors of Wei Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Qin. A scholar is included among the top collaborators of Wei Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Qin. Wei Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Teng, Chenguang Liu, Wei Qin, et al.. (2025). RBMD: A Molecular Dynamics Package Enabling to Simulate 10 Million All-Atom Particles in a Single Graphics Processing Unit. Communications in Computational Physics. 39(1). 1 indexed citations
3.
Li, Yanmei, Chao Deng, Jie Luo, et al.. (2025). Risk assessment of type I gastric neuroendocrine tumors based on endoscopic and clinical features of autoimmune gastritis. World Journal of Gastroenterology. 31(41). 111449–111449.
4.
Zou, Chun, et al.. (2025). Decoding immune cell dynamics in ischemic stroke: insights from single-cell RNA sequencing analysis. Frontiers in Aging Neuroscience. 17. 1549518–1549518.
5.
Qian, Cheng, et al.. (2024). Design and optimization of the seed feeding device with DEM-CFD coupling approach for rice and wheat. Computers and Electronics in Agriculture. 219. 108814–108814. 17 indexed citations
6.
Han, Mingming, Ji Liang, K. Wang, et al.. (2024). Integrin A5B1-mediated endocytosis of polystyrene nanoplastics: Implications for human lung disease and therapeutic targets. The Science of The Total Environment. 953. 176017–176017. 10 indexed citations
8.
Qin, Wei, et al.. (2024). Climate change vulnerability and conservation strategies for tertiary relict tree species: Insights from landscape genomics of Taxus cuspidata. Evolutionary Applications. 17(9). e13686–e13686. 2 indexed citations
9.
Kuang, Shuhong, Yong Zhang, Zongshan Shen, et al.. (2024). Multiomics profiling reveals VDR as a central regulator of mesenchymal stem cell senescence with a known association with osteoporosis after high-fat diet exposure. International Journal of Oral Science. 16(1). 41–41. 12 indexed citations
10.
Zhao, Xiaona, Zejin Zhang, Minghui Wang, et al.. (2024). Communication between nonalcoholic fatty liver disease and atherosclerosis: Focusing on exosomes. European Journal of Pharmaceutical Sciences. 193. 106690–106690. 7 indexed citations
11.
Peng, Jie, Wei Qin, Jiarong Li, et al.. (2023). Escherichia coli infection indicates favorable outcomes in patients with infected pancreatic necrosis. Frontiers in Cellular and Infection Microbiology. 13. 1107326–1107326. 1 indexed citations
12.
Liu, Qiang, Zhenyu Cao, Ju Zhang, et al.. (2022). TRPM8 deficiency attenuates liver fibrosis through S100A9-HNF4α signaling. Cell & Bioscience. 12(1). 58–58. 10 indexed citations
13.
Li, Jiarong, et al.. (2022). Early-onset emphysematous pancreatitis indicates poor outcomes in patients with infected pancreatic necrosis. Digestive and Liver Disease. 54(11). 1527–1532. 6 indexed citations
14.
Qin, Wei, Jing Zhang, Litao Zhang, et al.. (2022). Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4. Tissue and Cell. 78. 101867–101867. 5 indexed citations
15.
Qin, Wei, et al.. (2021). Synchronous organ failure and infected pancreatic necrosis define genuine critical acute pancreatitis. Digestive and Liver Disease. 53(12). 1590–1595. 4 indexed citations
16.
Sai, Chunmei, Wei Qin, Lina Gao, et al.. (2021). Macleayins A From Macleaya Promotes Cell Apoptosis Through Wnt/β-Catenin Signaling Pathway and Inhibits Proliferation, Migration, and Invasion in Cervical Cancer HeLa Cells. Frontiers in Pharmacology. 12. 668348–668348. 10 indexed citations
17.
Wang, Litao, et al.. (2020). Immunomodulatory and Antioxidant Activities of a Polysaccharide from Ligustrum vicaryi L. Fruit. Evidence-based Complementary and Alternative Medicine. 2020(1). 5431350–5431350. 10 indexed citations
18.
Xu, Yi, Yue Yao, Wei Qin, et al.. (2018). Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition. Biomedicine & Pharmacotherapy. 99. 121–127. 25 indexed citations
19.
Fěng, Fang, Lian‐Yue Yang, Yiming Tao, & Wei Qin. (2011). FBI‐1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo. Cancer. 118(1). 134–146. 35 indexed citations
20.
Meng, Xiao‐Ming, Jun Xiao, Arthur C.K. Chung, et al.. (2011). Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro. Kidney International. 81(3). 266–279. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026